Literature DB >> 7850799

Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.

M Ponzoni1, P Bocca, V Chiesa, A Decensi, V Pistoia, L Raffaghello, C Rozzo, P G Montaldo.   

Abstract

Retinoids exert various important biological effects in the control of normal growth, differentiation, and fetal development. While retinoic acid (RA) has entered clinical trials as a differentiation-promoting agent, it is only recently that the synthetic retinoid N-(4-hydroxyphenyl)retinamide (HPR) has been shown to be of potential clinical interest in cancer chemoprevention and treatment. Since thus far no data exist on the effects of HPR on neural crest cell-derived tumors, we have examined its in vitro effects on neuroblastoma (NB) cell lines and found that at relevant pharmacological concentrations it induces a dose-dependent growth inhibition. The antiproliferative effects of HPR were, in six of six cell lines tested, drastically more potent that those induced by an equimolar dose of RA. Time course growth analysis showed that HPR at 3 x 10(-6) M induces a very rapid (24-72 h) fall in thymidine uptake (> 90%), whereas at 3 x 10(-7) M it exhibits cytostatic effects. In contrast to RA, HPR did not show morphological changes typical of NB cell maturation nor did it induce the expression of any cytoskeletal protein associated with neuronal differentiation. DNA flow cytofluorimetric analysis revealed that HPR did not induce an arrest in a specific phase of the cell cycle while triggering apoptosis. This phenomenon was evidenced both by the visualization of "DNA ladders" on gel electrophoresis and by a quantitative assay for evaluating programmed cell death based upon the labeling of DNA breaks with tritiated thymidine. With the latter method, apoptotic cells were detectable as early as 3-6 h after treatment of NB cells with 10(-5) M HPR, while more than 50% of cells were apoptotic by 24-72 h following exposure to 3 x 10(-6) M HPR. In contrast, RA induced a low rate of apoptosis in NB cells only after 3-5 days. Time lapse photomicroscopy showed that NB cells treated with HPR underwent a death process highly reminiscent of apoptosis, with progressive condensation of the cytoplasm around the nucleus and intense cell shrinkage. The cells then rounded up and detached from the plate. Furthermore, propidium iodide staining of the DNA showed that a high proportion of cells treated with HPR displayed a small and brightly staining nucleus; chromatin appeared aggregated into dense masses in the nuclear periphery, a typical feature of apoptotic cells. In conclusion, our study demonstrates that contrary to the differentiation-promoting activity of RA, HPR dramatically suppresses NB cell growth by inducing programmed cell death.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7850799

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Authors:  Hua Fang; Theresa M Harned; Ondrej Kalous; Vanessa Maldonado; Yves A DeClerck; C Patrick Reynolds
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

2.  Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors.

Authors:  G P Tonini; K Mazzocco; A di Vinci; E Geido; B de Bernardi; W Giaretti
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.

Authors:  M V Corrias; F Guarnaccia; M Ponzoni
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

4.  Electromagnetic information delivery as a new tool in translational medicine.

Authors:  Foletti Alberto; Ledda Mario; Piccirillo Sara; Grimaldi Settimio; Lisi Antonella
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.

Authors:  Aintzane Apraiz; Jolanta Idkowiak-Baldys; Naiara Nieto-Rementería; María Dolores Boyano; Yusuf A Hannun; Aintzane Asumendi
Journal:  Biochem Cell Biol       Date:  2012-03-19       Impact factor: 3.626

6.  Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial.

Authors:  Ann M Mohrbacher; Allen S Yang; Susan Groshen; Shivaani Kummar; Martin E Gutierrez; Min H Kang; Denice Tsao-Wei; C Patrick Reynolds; Edward M Newman; Barry J Maurer
Journal:  Clin Cancer Res       Date:  2017-04-18       Impact factor: 12.531

7.  Retinamide-induced apoptosis in glioblastomas is associated with down-regulation of Bcl-xL and Bcl-2 proteins.

Authors:  Richard A Lytle; Zhihong Jiang; Xiao Zheng; Ryuji Higashikubo; Keith M Rich
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 8.  Oncogene-directed alterations in cancer cell metabolism.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2016-06-27

9.  Relationship between the ubiquitin-dependent pathway and apoptosis in different cells of the central nervous system: effect of thyroid hormones.

Authors:  L A Pasquini; C B Marta; A M Adamo; J M Pasquini; E F Soto
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

10.  p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.

Authors:  Veena Ganeshan; John Ashton; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.